Is Type 2 Diabetes a Glycogen Storage Disease of Pancreatic β Cells?

被引：71
作者：
Ashcroft, Frances M. [1 ,2 ]
Rohm, Maria [1 ,2 ]
Clark, Anne [3 ]
Brereton, Melissa F. [1 ,2 ]
机构：
[1] Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England
[2] Univ Oxford, OXION, Parks Rd, Oxford OX1 3PT, England
[3] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Churchill Hosp, Oxford OX3 7LJ, England
来源：
CELL METABOLISM | 2017年 / 26卷 / 01期
基金：
欧洲研究理事会; 英国惠康基金;
关键词：
INSULIN-RELEASE; GLUCOSE; METABOLISM; ACCUMULATION; ISLETS; GENE; AUTOPHAGY; SYNTHASE; PHOSPHORYLASE; EXPRESSION;
D O I：
10.1016/j.cmet.2017.05.014
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Elevated plasma glucose leads to pancreatic beta cell dysfunction and death in type 2 diabetes. Glycogen accumulation, due to impaired metabolism, contributes to this "glucotoxicity" via dysregulated biochemical pathways promoting b cell dysfunction. Here, we review emerging data, and re-examine published findings, on the role of glycogen in b cells in normoglycemia and in diabetes.
引用
收藏
页码：17 / 23
页数：7
相关论文
共 50 条
  • [31] Liver-directed gene therapy for murine glycogen storage disease type Ib
    Kwon, Joon Hyun
    Lee, Young Mok
    Cho, Jun-Ho
    Kim, Goo-Young
    Anduaga, Javier
    Starost, Matthew F.
    Mansfield, Brian C.
    Chou, Janice Y.
    HUMAN MOLECULAR GENETICS, 2017, 26 (22) : 4395 - 4405
  • [32] Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V)
    Quinlivan, Rosaline
    Martinuzzi, Andrea
    Schoser, Benedikt
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (11):
  • [33] Pharmacological and nutritional treatment for McArdle disease (Glycogen Storage Disease type V)
    Quinlivan, Rosaline
    Martinuzzi, Andrea
    Schoser, Benedikt
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (12):
  • [34] The fragility of liver glycogen from humans with type 2 diabetes: A pilot study
    Wang, Ziyi
    Min, Xiaobo
    Hu, Zhenxia
    Sullivan, Mitchell A.
    Tang, Yong
    Wang, Liang
    Gilbert, Robert G.
    Shi, Chen
    Deng, Bin
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2022, 221 : 83 - 90
  • [35] Dysregulation of muscle glycogen synthase in recovery from exercise in type 2 diabetes
    Pedersen, Andreas J. T.
    Hingst, Janne R.
    Friedrichsen, Martin
    Kristensen, Jonas M.
    Hojlund, Kurt
    Wojtaszewski, Jorgen F. P.
    DIABETOLOGIA, 2015, 58 (07) : 1569 - 1578
  • [36] The role of autophagy in the pathogenesis of glycogen storage disease type II (GSDII)
    A C Nascimbeni
    M Fanin
    E Masiero
    C Angelini
    M Sandri
    Cell Death & Differentiation, 2012, 19 : 1698 - 1708
  • [37] Aberrant glucose metabolism underlies impaired macrophage differentiation in glycogen storage disease type Ib
    Jang, Yuyeon
    Park, Tae Sub
    Park, Byung-Chul
    Lee, Young Mok
    Heo, Tae-Hwe
    Jun, Hyun Sik
    FASEB JOURNAL, 2023, 37 (11)
  • [38] Partial correction of neutrophil dysfunction by oral galactose therapy in glycogen storage disease type Ib
    Letkemann, Rudolf
    Wittkowski, Helmut
    Antonopoulos, Aristotelis
    Podskabi, Teodor
    Haslam, Stuart M.
    Foell, Dirk
    Dell, Anne
    Marquardt, Thorsten
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 44 : 216 - 225
  • [39] Why does the immune system destroy pancreatic β-cells but not α-cells in type 1 diabetes?
    Eizirik, Decio L.
    Szymczak, Florian
    Mallone, Roberto
    NATURE REVIEWS ENDOCRINOLOGY, 2023, 19 (07) : 425 - 434
  • [40] Glycogen storage disease type VI: clinical course and molecular background
    Aeppli, Tim R. J.
    Rymen, Daisy
    Allegri, Gabriella
    Bode, Peter K.
    Haeberle, Johannes
    EUROPEAN JOURNAL OF PEDIATRICS, 2020, 179 (03) : 405 - 413
12345